2025 annual financial data
Nurix Therapeutics, Inc. 2025 Operating margin
Nurix Therapeutics, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was -340.16%.
Operating income was -285,666,000 USD and net income was -264,457,000 USD.
Operating cash flow was -249,465,000 USD.
Get free Nurix Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 83,980,000 USD
- Operating income
- -285,666,000 USD
- Net income
- -264,457,000 USD
- Operating cash flow
- -249,465,000 USD